Enrollment in Human Absorption Study Starts in Zambia
Enrollment in Human Absorption Study Starts in Zambia
Particles for Humanity has initiated the enrollment of participants at a study site in Zambia for its innovative human absorption research focusing on PFH-VAP, a stable formulation of vitamin A. This significant study aims to validate that the enhanced stability of PFH-VAP results in the efficient delivery of vitamin A to the human body after consumption.
Study Collaboration and Objective
This research is taking place in collaboration with the University of Wisconsin–Madison and the National Health Research Institute (NHRTI). It represents an important step towards addressing vitamin A deficiency worldwide through large-scale food fortification strategies.
The enrollment in Zambia marks the second and final site for this crucial study. The successful enrollment targets at the University of Wisconsin–Madison, the first site of this study, have already been achieved, paving the way for the next phase.
Understanding the Study's Execution
In this study, participants will consume bouillon fortified with PFH-VAP along with a commercial vitamin A fortified bouillon. Researchers anticipate that PFH-VAP’s advanced stability will lead to superior vitamin A levels in participants when compared to the commercially available alternative.
This initiative has secured Institutional Review Board (IRB) approval, ensuring that all ethical standards are upheld. The study has received endorsements from various regulatory authorities, confirming its credibility and commitment to participant safety.
Key Insights From the Research Team
Dr. Justin Chileshe, a Research Scientist at the NHRTI and co-principal investigator of the study, expressed his enthusiasm, stating, "We are thrilled to start enrollment in Zambia, the second and final entry point of this important study. Vitamin A is vital for our population’s health, and we are committed to helping Particles for Humanity distribute more of this life-saving nutrient to those in need."
The Promise of PFH-VAP
PFH-VAP has been specifically developed to maintain its potency in challenging conditions typically found in subtropical regions, thus addressing the issue of vitamin A instability. Traditional vitamin A sources often lose much of their nutritional benefit before reaching consumers. In contrast, PFH-VAP retains 70% of its vitamin A content after one year of storage in bouillon, showcasing a fourfold stability advantage over the conventional product.
Integrating PFH-VAP into food products like bouillon can significantly enhance the nutritional intake of vitamin A, potentially saving lives and improving overall well-being for those affected by vitamin A deficiency.
About the Research
The Principal Investigator of this study, Dr. Sherry Tanumihardjo, is a respected Professor of Nutritional Sciences at the University of Wisconsin–Madison, lending her expertise to this vital research. The study is officially registered on ClinicalTrials.gov under the identifier NCT06438562.
Mission of Particles for Humanity
Particles for Humanity is dedicated to transforming early-stage medical innovations into practical solutions targeted at communities in low and lower-middle-income countries. The organization relies entirely on philanthropic funding, ensuring that its development processes are designed with end-user feedback and focused on creating financially sustainable product opportunities. To learn more about their mission and initiatives, visit www.particlesfh.com.
Frequently Asked Questions
What is the purpose of the PFH-VAP study?
The study aims to verify the effectiveness of PFH-VAP in delivering more vitamin A to the human body compared to conventional sources.
Who is involved in this study?
The research is a collaboration between Particles for Humanity, the University of Wisconsin–Madison, and the National Health Research Institute.
What are the benefits of PFH-VAP?
PFH-VAP maintains higher stability and retains more vitamin A under conditions that typically affect its efficacy, offering a superior solution for food fortification.
Where is the study taking place?
The study is being conducted in Zambia at a designated research site as well as at the University of Wisconsin–Madison.
How can I get involved in the study?
Interested participants can inquire about enrollment at the study sites to learn about eligibility and registration processes.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.